SUMMARY
For more than 30 years, Gianrico Farrugia, M.D., has led a National Institutes of Health-funded translational research program focused on understanding how the enteric nervous system and gastrointestinal smooth muscle work together to regulate digestive function, and how these processes are disrupted in disease. Dr. Farrugia investigates the molecular and cellular mechanisms that drive normal gastrointestinal function and the biological defects that lead to digestive disorders.
His work has transformed scientific understanding of how mechanical forces regulate cellular signaling and function throughout the gastrointestinal tract. His landmark discoveries include demonstrating that voltage-gated ion channels, including Nav1.5, are mechanosensitive and play a key role in gastrointestinal motility. He has identified mechanosensitive ion channels as critical regulators of both motor and nonmotor gastrointestinal function, including age-related changes.
Through innovative experimental approaches and pioneering mechanistic studies, Dr. Farrugia's research has advanced the field of gastrointestinal neuroscience and opened new avenues for developing targeted therapies for patients with digestive diseases.
Focus areas
Role of ion channels in gastrointestinal function
Characterizes ion channels in human gastrointestinal cells, identifying key channels that regulate motility and electrical activity. This work has uncovered disease-causing channel defects in disorders such as gastroparesis, pseudo-obstruction and irritable bowel syndrome, while revealing new therapeutic targets.
Mechanosensitive ion channels
Proves that ion channels in the gastrointestinal tract respond not only to electrical and chemical signals but also to mechanical forces. This work established the mechanosensitivity of channels such as Nav1.5 and defined molecular mechanisms linking tissue stiffness, aging and gastrointestinal dysmotility.
Diabetic gastroparesis
Investigates the cellular and molecular mechanisms underlying diabetic gastroparesis, identifying critical roles for interstitial cells of Cajal and immune cell populations. This work demonstrated that restoring protective macrophage signaling can reverse disease in preclinical models and provided a foundation for novel therapies.
Interstitial cells of Cajal and motility disorders
Establishes interstitial cells of Cajal as central regulators of gastrointestinal motility and identify their loss or dysfunction as a key feature of disorders including slow-transit constipation, gastroparesis and intestinal pseudo-obstruction. This work has driven the development of targeted treatments aimed at restoring normal gut function.
Carbon monoxide signaling in the gastrointestinal tract
Demonstrates that physiologic levels of carbon monoxide play an essential role in maintaining normal gastrointestinal function. This work explores carbon monoxide- and heme oxygenase-1-based therapies for diabetic gastroparesis and other diseases, with the goal of translating these findings into new clinical treatments.
Significance to patient care
Dr. Farrugia's research is focused on improving the lives of patients with debilitating digestive disorders, including diabetic gastroparesis, slow-transit constipation and irritable bowel syndrome. By uncovering the root causes of these disorders, his research seeks to develop targeted treatments that relieve symptoms, address underlying disease processes, restore normal gastrointestinal function, and improve quality of life for patients worldwide.
Professional highlights
- Mayo Clinic:
- John H. Noseworthy, M.D., and Jay Alix Distinguished Chair, 2019-present.
- President and chief executive officer, 2019-present.
- Director, Enteric Neuroscience Program, 1999-present.
- Chief executive officer (Florida), 2015-2018.
- Vice president, 2015-2018.
- Ellis Island Medals of Honor, Ellis Island Honors Society, 2023.
- Honorary doctorate, University of Malta, 2021.
- Research Mentor Award, Neurogastroenterology and Motility Section, American Gastroenterological Association, 2019.
- President, American Neurogastroenterology and Motility Society, 2016-2018.
- Basic science editor, Neurogastroenterology & Motility, 2011-2015.